|
|
|
|
Learn about the key manufacturing principles of lentiviral (LV) vectors for clinical trials or commercial use, regulatory considerations specific to the testing requirements of LV vectors, and testing strategies for LV vectors with a particular focus on the replication-competent virus assay and infectious titer assay.
|
|
|
|
|
Explore how rapid testing for sterility, mycoplasma, and RCL supports safer, faster cell and gene therapy development to help teams reduce risk, meet regulatory demands, and keep pace with a rapidly expanding therapeutic landscape.
|
|
|
|
|
Cell therapy manufacturing for Phase 1 trials demands precision, speed, and coordination. Examine how cross-functional teams streamline cell therapy manufacturing and release for Phase 1 trials to meet patient timelines and ensure safe delivery of personalized treatments.
|
|
|
|
|
Find out how Next Generation Sequencing improves CRISPR specificity by enhancing sgRNA quality control, reducing off-target effects, and increasing sequence fidelity—key steps for achieving more accurate and reproducible gene editing results.
|
|
|
|
|
|
|
With scalable capacity, rapid turnaround, and proven regulatory record across global frameworks, we partner with developers and CDMOs to deliver fast, consistent and high-quality testing services for complex cell therapy platforms. Learn more.
|
|
|
